This inventor holds 1 USPTO granted patent. Top assignee: Bohai University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations of Ying Bu in Phage Research
Introduction
Ying Bu is an accomplished inventor based in Jinzhou, China. He has made significant contributions to the field of phage research, particularly with his innovative work on virulent phages. His research focuses on the preparation and application of specific phages, which have important implications for controlling bacterial infections.
Latest Patents
Ying Bu holds a patent for a virulent phage, designated as ΦPf1901, along with its preparation and application. This invention is detailed in his patent titled "Virulentphage ΦPf1901, and phage ΦPf901 preparation and application thereof." The virulent phage ΦPf1901 has an accession number of CCTCC M2019447. It exhibits a titer of (1.4-3)×10 PFU/mL and an optimal multiplicity of infection (MOI) value of 0.0001. The phage demonstrates high specificity and lytic ability, making it a valuable tool for controlling bacterial populations.
Career Highlights
Ying Bu is affiliated with Bohai University, where he conducts his research and contributes to the academic community. His work has garnered attention for its potential applications in medical and environmental fields. With a focus on phage technology, he continues to explore innovative solutions to combat bacterial infections.
Collaborations
Ying Bu collaborates with notable colleagues, including Jian Zhang and Tingting Li. Their combined expertise enhances the research efforts and broadens the impact of their findings in the scientific community.
Conclusion
Ying Bu's contributions to phage research exemplify the importance of innovation in addressing contemporary challenges in microbiology. His patent on virulent phage ΦPf1901 highlights the potential of phage therapy as a viable alternative to traditional antibiotics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile